Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
BMC Nephrology|December 4, 2013
Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional statusMarlies Antlanger, Manfred Hecking, Michael Haidinger, et al.
Cell Death and Differentiation|February 16, 2018
EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiationMarkus Linder, Manfred Hecking, Elisabeth Glitzner, et al.
International Journal of Cardiology|January 8, 2017
Fluid status and outcome in patients with heart failure and preserved ejection fractionBenedikt Koell, Caroline Zotter-Tufaro, Franz Duca, et al.
BMJ Open|October 11, 2022
Experiences and challenges faced by patients with COVID-19 who were hospitalised and participated in a randomised controlled trial: a qualitative studyLukas Hofstetter, Viktoria Tinhof, Hannah Mayfurth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 7, 2019
Associations between Hemodialysis Facility Practices to Manage Fluid Volume and Intradialytic Hypotension and Patient OutcomesIndranil Dasgupta, G Neil Thomas, Joanne Clarke, et al.
Pain|May 27, 2020
Patients' perspectives of pain in dialysis: systematic review and thematic synthesis of qualitative studiesKelly Zhang, Elyssa Hannan, Nicole Scholes-Robertson, et al.
Clinical Kidney Journal|August 4, 2025
Longitudinal patterns of fluid overload, blood volume and vascular refilling: a prospective study in patients on maintenance hemodialysisSebastian Mussnig, Simon Krenn, Max Waller, et al.
BMC Nephrology|July 19, 2017
Blood volume-monitored regulation of ultrafiltration to decrease the dry weight in fluid-overloaded hemodialysis patients: a randomized controlled trialMarlies Antlanger, Peter Josten, Michael Kammer, et al.
Diabetes, Obesity & Metabolism|January 5, 2022
Combined sodium glucose co-transporter-2 inhibitor and angiotensin-converting enzyme inhibition upregulates the renin-angiotensin system in chronic kidney disease with type 2 diabetes: Results of a randomized, double-blind, placebo-controlled exploratory trialMarlies Antlanger, Oliver Domenig, Christopher C Kaltenecker, et al.
Scientific Reports|January 18, 2023
The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammationLukas Hartl, Benedikt Rumpf, Oliver Domenig, et al.
Pageof 11